| Literature DB >> 35571474 |
Petros Stathopoulos1, Malte Zumblick1, Sabine Wächter2, Leif Schiffmann3, Thomas M Gress4, Detlef Bartsch2, Guido Seitz5, Ulrike W Denzer1.
Abstract
Background and study aims Acute esophageal perforation is a potentially life-threating condition that demands a multidisciplinary approach. Based on recently published data indicating that EVT may be effective in managing esophageal perforation, we report our institution's experience with EVT in this clinical setting. Patients and methods We retrospectively analyzed all 10 patients with acute esophageal perforation from May 2018 to January 2021, using descriptive statistics. The primary outcome was successful closure of the perforation. Secondary outcomes included the length of treatment, number of endoscopic procedures required, and complication rate. Results All patients (site of perforation: 4 upper, 2 middle, 4 lower esophagus; etiology: 8 iatrogenic, 2 foreign body ingestion) were treated with EVT successfully. In eight cases, EVT was started immediately after the perforation, in the other two cases 1 and 2 days later. The median (interquartile range) number of endoscopic procedures was 2.5 (range, 2-3) and the median duration of treatment was 7.5 days (range, 7-11.5). The sponge was placed in eight cases intraluminally, in the other two cases initially intracavitary. No complication occurred. Conclusions EVT is highly effective for managing acute esophageal perforation within 1 to 3 weeks. Immediate start of EVT to prevent abscess formation and induce defect closure is crucial. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).Entities:
Year: 2022 PMID: 35571474 PMCID: PMC9106444 DOI: 10.1055/a-1781-0827
Source DB: PubMed Journal: Endosc Int Open ISSN: 2196-9736
Fig. 1Technical preparation of EVT. a Eso-SPONGE kit. b Endoscope serves as a guide rail for insertion of the overtube. c, d Sponge placement via overtube with a pusher. e Sponge insertion without overtube by creating an air knot at the proximal end of the sponge after stitching through the tube and capturing the knot by a grasping forceps.
Baseline patient and procedure characteristics.
| No. patients (n = 10) | |
| Age, years, median (IQR) | 68.5 (39.5–76.8) |
| Sex, n (%) | |
Male | 4 (40) |
Female | 6 (60) |
| Etiology of perforation, n (%) | |
Pneumatic balloon dilation with 30-mm Rigiflex balloon | 4 (40) |
Foreign body | 2 (20) |
Diagnostic EGD, pemphigus vulgaris | 1 (10) |
Removal of food bolus | 1 (10) |
Caustic stricture | 1 (10) |
Endoscopic-assisted diverticulotomy | 1 (10) |
| Anatomical location, n (%) | |
Upper esophagus | 4 (40) |
Middle esophagus | 2 (20) |
Lower esophagus | 4 (40) |
| Size of the perforation, mm, median (IQR) | 17.5 (15–20) |
| Time until start of EVT after perforation, days, median (range) | 0 (0–2) |
| Position of the sponge, n (%) | |
Intraluminal | 8 (80) |
Intracavitary & intraluminal | 2 (20) |
| No of Eso-SPONGE change, mean (IQR) | 2.5 (2–3) |
| Treatment duration, days | 7.5 (7–11.5) |
| Complete closure of the perforation, n (%) | 10 (100) |
| Clinical follow-up, months, median (IQR) | 8 (1.3–18.3) |
IQR, interquartile range; EGD, esophagogastroduodenoscopy; EVT, endoscopic vacuum therapy.
Detailed patient and procedure characteristics.
| Case | Age, years | Sex | Etiology of perforation | Anatomical location | Size, mm | Days after perforation to sponge placement | Position of the sponge | Eso-SPONGE changes, n | Treatment duration, days | Complete closure |
| 1 | 66 | F | Diagnostic EGD; pemphigus vulgaris | Upper esophagus | 10 | 1 | Intraluminal | 2 | 7 | + |
| 2 | 25 | M | Foreign body (glass piece) | Upper esophagus | 20 | 0 | Intraluminal | 3 | 12 | + |
| 3 | 33 | F | Foreign body (pen) | Upper esophagus | 10 | 0 | Intraluminal | 2 | 8 | + |
| 4 | 79 | F | Endoscopic-assisted-diverticulotomy | Upper esophagus | 15 | 0 | Intraluminal | 1 | 3 | + |
| 5 | 59 | M | Removal of food bolus | Middle esophagus | 15 | 0 | Intraluminal | 2 | 7 | + |
| 6 | 3 | F | Caustic stricture | Middle esophagus | 20 | 0 | Intraluminal | 3 | 10 | + |
| 7 | 73 | F | Pneumatic dilation, achalasia | Lower esophagus | 50 | 0 | Intracavitary and intraluminal | 5 | 21 | + |
| 8 | 78 | M | Pneumatic dilation, achalasia | Lower esophagus | 20 | 0 | Intraluminal | 1 | 4 | + |
| 9 | 79 | M | Pneumatic dilation, achalasia | Lower esophagus | 30 | 0 | Intraluminal | 3 | 7 | + |
| 10 | 71 | F | Pneumatic dilation, achalasia | Lower esophagus | 20 | 2 | Intracavitary and intraluminal | 5 | 20 | + |
EGD, esophagogastroduodenoscopy; F, female; M, male.
Fig. 2Perforation of the upper esophagus after ingestion of a pen. a The pen was captured with a snare. b Perforation after removal of the pen. c Intraluminal placement of the sponge just below the upper esophageal sphincter. d Perforation closure endoscopically confirmed.
Fig. 3Perforation of the middle esophagus in a child with caustic stricture. a CT scan topogram of a tension pneumothorax. b Intraluminal placement of the sponge. C Site of perforation on Day 3. d Perforation closure on Day 7. e End of EVT on Day 10. f Complete closure documented after injection of contrast through the scope in the esophagus.
Fig. 4Perforation of the lower esophagus after pneumatic balloon dilation for achalasia. a Large perforation with a mediastinal cavity at an early stage (Day 0). b Intracavitary placement of the sponge. c Condition after 3 days of EVT. d Smaller perforation defect after 7 days of EVT. e Perforation closure endoscopically confirmed.
EVT for esophageal perforations.
| Author | Journal | Patients | Defect size, mm | Success rate, n (%) | Mortality rate, n (%) | Complication rate, n (%) | Days after perforation to sponge placement | Sponge changes, n, median | Duration of therapy, days, median | Position of the sponge |
|
Mastoridis et al.
| Minim Invasive Ther Allied Technol. 2020 | 3 | NA | 3 (100) | 0 (0) | 0/3 (0) | 1 (0–8) | 3 | 13 | IL 3/IC 0 |
|
Jung et al.
| Digestion 2020 | 7 | NA |
5 (71.4)/4 (57.1)
| 1 (14.3) | NA | NA | 6.4 | 25.5 | IL 4/IC 3 |
|
Leeds et al.
| J. Gastrointest. Surg. 2019 | 17 | NA | 16 (94) | NA | NA | 12.8 | 5.2 | 23.8 | NA |
|
Bludau et al.
| Surg. Endosc. 2018 | 18 | NA | 13 (72.2) | 3 (16.7) | NA | NA |
2.8
|
8.8
|
IL 14/IC 5
|
|
Pournaras et al.
| World J. Surg. 2018 | 14 | NA | 13 (92.9) | 2 (14.9) | NA | NA | NA | NA | NA |
|
Ooi et al.
| ANZ J. Surg. 2018 | 5 | 20 | 3 (60) | 1 (20) | NA | 5 | 6 | 20 | NA |
|
Laukoetter et al.
| Surg. Endosc. 2017 | 13 | NA |
49 (94.2)/42 (80.8)
| 0 | 0 |
5
|
6
|
23.5
| NA |
|
Kuehn et al.
| J. Gastrointest. Surg. 2016 | 10 | NA | 10 (100) | NA | 0 | NA | 5 | 15 | NA |
|
Moschler et al.
| Endosc. Int. Open 2015 | 5 | NA | 5 (100) | NA | NA | NA | 0 (range 0–6) | 5 | IL 3/IC 2 |
|
Loske et al.
| Endosc. Int. Open 2015 | 10 | 12,5 | 10 (100) | 0 | 0 | 0 | 1 | 5 | IL 8/IC 2 |
|
Heits et al.
| Ann. Thorac. Surg. 2014 | 10 | NA |
9 (90)/7 (70)
| 1 (10) | 7 (70) | NA | 5.4 | NA | NA |
EVT, endoscopic vacuum therapy; NA, not available; IL, intraluminal; IC, intracavitary.
EVT alone.
spontaneous perforations.
Iatrogenic perforations.
Combination possible.
Overall success, not separately for perforations.